Hermetica Superfood Encyclopedia
The Short Answer
Nauclea diderrichii leaf extracts contain alkaloids, flavonoids, and phenolic compounds that are believed to disrupt Plasmodium falciparum parasite growth through mechanisms not yet fully characterized at the molecular level. In the most quantified in vitro study available, an ethanol leaf extract achieved 87.83% parasite elimination at 5000 µg/mL against P. falciparum, though no human clinical trials have been conducted to translate this into confirmed therapeutic dosing.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAfrican Peach Nauclea diderrichii benefits
African Peach — botanical close-up
Health Benefits
**Antiplasmodial Activity**: Ethanol leaf extracts of N
diderrichii demonstrated up to 87.83% elimination of Plasmodium falciparum parasites in vitro at 5000 µg/mL, with the ethyl acetate fraction (Nd-F3) also showing 86.33% elimination, supporting traditional use against malaria.
**Antimicrobial Potential**
Alkaloids and phenolic compounds present in the leaf extract are associated with broad antimicrobial properties documented across the Nauclea genus, though species-specific antibacterial data for N. diderrichii remains limited.
**Anti-inflammatory Properties**
Flavonoids and terpenoids identified in leaf fractions are compound classes widely recognized for inhibiting pro-inflammatory mediators, suggesting a mechanistic basis for the plant's traditional use in fever and pain management.
**Antipyretic Use in Traditional Medicine**
The plant is employed in Nigerian folk medicine—particularly in Zamfara State—to reduce fever, consistent with the anti-inflammatory and antiplasmodial phytochemical profile of its leaf extracts.
**Antioxidant Capacity**
Phenolic compounds, tannins, and flavonoids present in the ethyl acetate and dichloromethane fractions are established free-radical scavengers, suggesting antioxidant potential that may contribute to its protective effects against oxidative-stress-driven pathology.
**Analgesic Potential**
Genus-level ethnopharmacological reviews document the use of Nauclea species for pain relief, with terpenoids and alkaloids in N. diderrichii representing plausible bioactive contributors to this effect, though direct analgesic studies for this species are absent.
Origin & History
Natural habitat
Nauclea diderrichii is a medium-to-large tropical hardwood tree native to the moist lowland rainforests and gallery forests of West and Central Africa, with documented presence in Nigeria, Cameroon, Ghana, and the Democratic Republic of Congo. It thrives in humid, high-rainfall zones at low to mid elevations, often growing along riverbanks and forest margins. The species is considered commercially and ecologically threatened due to heavy logging for its durable timber, which has historically overshadowed its medicinal recognition.
“Nauclea diderrichii has been integrated into West African traditional medicine systems for generations, with documented ethnomedicinal use in northern Nigeria—particularly among communities in Gusau, Zamfara State—where healers employ leaf preparations to manage malaria, fever, and general illness. The tree holds dual cultural significance as both a medicinal resource and a high-value timber species known locally by names such as 'opepe' in Yoruba-speaking regions, which has ironically contributed to its threatened conservation status through over-harvesting for the lumber trade. Across the broader Nauclea genus, which spans West Africa and Southeast Asia, species have been incorporated into diverse ethnopharmacological traditions for pain, fever, and infectious disease, forming a coherent cross-cultural pattern of use that lends ethnobotanical credibility to the species-level claims. No ancient written pharmacopoeias specifically document N. diderrichii, but oral traditions and contemporary ethnobotanical surveys conducted in Nigerian communities provide the primary historical record of its medicinal application.”Traditional Medicine
Scientific Research
The body of evidence for N. diderrichii is strictly preclinical and limited in volume; the most substantive available data originates from in vitro antiplasmodial assays testing ethanol crude extract and three solvent fractions against chloroquine-sensitive P. falciparum strains, with parasite elimination percentages reported rather than IC50 values, limiting direct pharmacological comparison. No randomized controlled trials, observational human studies, or pharmacokinetic studies have been published for this species, representing a significant evidentiary gap. Genus-level reviews for Nauclea broadly support traditional antimalarial and analgesic uses across multiple species, but extrapolation to N. diderrichii specifically requires caution given the phytochemical variability between congeners. Toxicological data is essentially absent—one referenced study employed a brine shrimp lethality assay but published no LC50 values—meaning the therapeutic index cannot be estimated from current literature.
Preparation & Dosage
Traditional preparation
**Traditional Ethanol Extract (Research Preparation)**
1000 g of powdered dried leaves percolated in 3 liters of absolute ethanol for one week with periodic shaking; filtered and concentrated via rotary evaporator at 40°C to yield crude extract (Nd-ET)
Approximately .
**Solvent Fractions**
Crude ethanol extract further partitioned into n-hexane fraction (Nd-F1), dichloromethane fraction (Nd-F2), and ethyl acetate fraction (Nd-F3) for research purposes; ethyl acetate fraction consistently showed strong antiplasmodial activity.
**In Vitro Concentrations Tested**
625 µg/mL to 5000 µg/mL used in antiplasmodial assays; these laboratory concentrations cannot be directly translated to human oral dosing without pharmacokinetic study.
**No Standardized Commercial Form**
No standardized extract, capsule, tincture, or tablet form has been established or commercialized; no standardization percentage for any marker compound has been defined.
**Traditional Folk Use**
In Nigerian communities, leaf preparations are used informally as decoctions or macerations for fever and malaria; specific volumes and weights used in traditional practice are not documented in peer-reviewed literature.
Nutritional Profile
Nauclea diderrichii has not been evaluated as a food or dietary supplement source, and no nutritional composition data—including macronutrients, minerals, or vitamins—has been published for its leaves, bark, or fruit. The primary characterized constituents are phytochemical rather than nutritional: alkaloids (including indoloquinolizidine-type structures characteristic of Rubiaceae), flavonoids, phenolic acids, tannins, saponins, cardiac glycosides, phytosterols, terpenoids, and carbohydrates, all identified qualitatively in leaf extracts. Specific concentrations of any individual compound have not been quantified using techniques such as HPLC or LC-MS in available literature, making it impossible to define a phytochemical potency profile. Bioavailability of the bioactive alkaloids and flavonoids via oral ingestion in humans is entirely unstudied, and factors such as first-pass metabolism, gut microbiome interactions, and matrix effects remain uncharacterized.
How It Works
Mechanism of Action
The antiplasmodial mechanism of N. diderrichii leaf extracts has not been characterized at the molecular level in published studies; however, the dominant bioactive classes—indoloquinolizidine alkaloids and flavonoids—are hypothesized to disrupt Plasmodium falciparum growth through interference with parasite metabolic processes, potentially including heme detoxification inhibition or disruption of folate biosynthesis, based on analogy with structurally related Rubiaceae alkaloids. Flavonoids identified in the ethyl acetate fraction (Nd-F3) may additionally act through inhibition of parasite-specific enzymes such as falcipain or plasmepsin proteases, which are critical to hemoglobin digestion by the parasite. Phenolic compounds and tannins may contribute through membrane destabilization or oxidative stress induction within the parasite. The saponin content may enhance cellular uptake of other bioactive molecules by increasing membrane permeability, though no mechanistic studies have confirmed this synergistic action specifically for N. diderrichii.
Clinical Evidence
No human clinical trials have been conducted on Nauclea diderrichii in any therapeutic context. The entirety of quantified efficacy data derives from a single in vitro antiplasmodial study using ethanol leaf extract fractions tested against Plasmodium falciparum, reporting parasite elimination rates of 75.50%–87.83% for the crude extract and 72.65%–86.33% for the ethyl acetate fraction across concentrations of 625–5000 µg/mL; no IC50 values, control comparisons against standard antimalarials, or statistical analyses are reported. Confidence in therapeutic application to humans is very low given the absence of pharmacokinetic data, dose-translation models, or safety profiling. Significant investment in preclinical toxicology, dose-finding animal studies, and eventually Phase I human trials would be required before any clinical conclusions could be drawn.
Safety & Interactions
The safety profile of Nauclea diderrichii is essentially unestablished; no formal acute or chronic toxicity studies in animal models have been published with quantitative outcomes, and human safety data is entirely absent from the peer-reviewed literature. A brine shrimp lethality assay was referenced in one study as a preliminary cytotoxicity screen, but no LC50 or results were reported, providing no usable safety threshold. The presence of cardiac glycosides in leaf extracts is a notable pharmacological concern, as this compound class can cause serious cardiotoxicity at elevated doses and may interact with digoxin, antiarrhythmic agents, and electrolyte-altering medications; co-administration with these drug classes should be avoided until safety data is available. Contraindications for pregnancy, lactation, pediatric use, and individuals with hepatic or renal impairment cannot be defined due to the absence of relevant studies, and the precautionary principle strongly recommends against unsupervised use in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Nauclea diderrichiiOpepeAfrican peach treeSarhonEgbi
Frequently Asked Questions
Does African Peach actually work against malaria?
In vitro laboratory studies show that ethanol leaf extracts of Nauclea diderrichii can eliminate up to 87.83% of Plasmodium falciparum parasites at 5000 µg/mL, which provides biological plausibility for its traditional antimalarial use. However, no human clinical trials have been conducted, meaning there is no direct evidence that oral consumption translates to effective malaria treatment in people. Until pharmacokinetic and clinical studies are completed, it cannot be recommended as a replacement for established antimalarial therapies.
What are the active compounds in African Peach leaves?
Phytochemical screening of Nauclea diderrichii leaf extracts has identified alkaloids (including indoloquinolizidine-type compounds characteristic of the Rubiaceae family), flavonoids, phenolic acids, tannins, saponins, cardiac glycosides, phytosterols, and terpenoids. While these compound classes have been confirmed qualitatively across multiple solvent fractions, no study has yet quantified the concentration of individual compounds using HPLC or mass spectrometry. The alkaloids and flavonoids are considered the most likely contributors to the observed antiplasmodial activity.
Is African Peach safe to consume or use medicinally?
The safety of Nauclea diderrichii has not been formally evaluated; no animal toxicity studies with quantitative outcomes or human safety trials have been published. A significant concern is the presence of cardiac glycosides in leaf extracts, a compound class known to cause dose-dependent cardiotoxicity and to interact with heart medications such as digoxin. Until robust toxicological data is available, self-medicating with preparations of this plant carries undefined risk and is not advisable without medical supervision.
How is African Peach traditionally prepared in West African medicine?
In Nigerian folk medicine, particularly in communities in Zamfara State, leaves of Nauclea diderrichii are prepared as decoctions or macerations for treating fever and malaria, though specific traditional measurements are not well-documented in scientific literature. Research laboratories have replicated and formalized this process by percolating approximately 1000 g of powdered dried leaves in 3 liters of absolute ethanol for one week, then concentrating the extract via rotary evaporation at 40°C. This yields a crude ethanol extract that is further fractionated into n-hexane, dichloromethane, and ethyl acetate fractions for scientific study.
Is Nauclea diderrichii endangered or threatened?
Yes, Nauclea diderrichii is considered a threatened species, primarily due to intensive logging for its dense, durable hardwood timber which is commercially valued across West and Central Africa. Conservation concerns have been explicitly raised in ethnopharmacological literature, which calls for sustainable harvesting practices and cultivation programs to preserve the species for both ecological and medicinal purposes. Researchers have specifically flagged this conservation status as a factor complicating the further study and potential commercialization of its medicinal properties.
What is the difference between African Peach leaf extract and whole leaf preparations?
Leaf extracts concentrate the active alkaloids and phenolic compounds responsible for antiplasmodial activity, with ethanol and ethyl acetate extracts demonstrating up to 87.83% parasitic elimination in laboratory studies. Whole leaf preparations may contain these compounds but at lower concentrations and with variable potency depending on preparation method and plant part used. Extract-based formulations are typically more standardized for medicinal use, whereas whole leaf preparations reflect traditional practices but with less predictable efficacy.
Does African Peach interact with antimalarial medications like artemisinin or quinine?
Limited clinical data exists on direct interactions between Nauclea diderrichii and synthetic antimalarial drugs, though both contain bioactive compounds that affect parasite metabolism. Because African Peach demonstrates independent antiplasmodial activity through its alkaloid content, concurrent use with prescription antimalarials requires medical supervision to avoid duplicative mechanisms or reduced efficacy of either treatment. Anyone taking antimalarial medications should consult a healthcare provider before adding African Peach supplementation.
What does current research suggest about African Peach's effectiveness compared to established malaria treatments?
In vitro studies show African Peach leaf extracts achieve parasitic elimination rates (up to 87.83%) comparable to some laboratory benchmarks, but these results have not been validated in human clinical trials or randomized controlled studies. Traditional use in West Africa over centuries supports antimalarial efficacy, yet clinical evidence remains limited compared to FDA-approved or WHO-endorsed antimalarial drugs. The ingredient shows promising research potential but should not replace proven antimalarial treatments without medical guidance.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w african-peach-nauclea-diderrichii curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
